Light Treatment of Vaginal Infections in Reproductive Age Women

Launched by UVISA HEALTH APS · May 21, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to treat common vaginal infections, specifically bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), using light as a treatment. Researchers are looking into whether this light treatment can be safe and effective, especially as traditional antibiotics are becoming less effective due to rising resistance. The trial is not yet recruiting participants, but it will focus on women aged 18 to 45 who have been diagnosed with BV or VVC and do not have any other genital infections.

To participate in the trial, women must be in good gynecological health and not pregnant. Those currently taking other medications for vaginal infections or who have recent treatments for other genital conditions may not be eligible. If you join the study, you can expect to receive treatment with light and be monitored for any effects it may have on your infection. This trial is important as it aims to find new solutions for infections that are becoming harder to treat.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 18-45 years of age
• • Normal gynecological status
• • Diagnosed for BV or VVC
• • Not pregnant
• • No signs of other genital tract infections
• Exclusion Criteria:
• • Current signs of other genital tract infection including STD
• • Concomitant medication for treatment of vaginal infections or use of any intravaginal medication during the clinical investigation
• • Pregnancy
• • Current genital malignancies, chemotherapy for any reason within the last 6 months, previous radiotherapy in the genitourinary system. Cervical dysplasia diagnosis or treatment within the last 3 months (where applicable)